An Innovative Approach

Changing How Respiratory Tract Conditions Are Treated

About us

Airiver Medical is a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions. The company aims to improve the current standard of care for the following conditions:

  • Central airway stenosis
  • Chronic rhinosinusitis (CRS)

One Minimally Invasive Technology, Two Target Indications

Airiver Medical’s Drug Coated Balloon could offer a new solution for these conditions, potentially creating sustained patency, better outcomes and fewer treatments.

Airiver Medical’s Drug Coated Balloon is an investigational device and is not available for sale in the U.S.

Pulmonary

Central Airway Stenosis

Airway narrowing, often associated with prolonged intubation, tracheostomy, stenting, tuberculosis or transplant. It includes subglottic, tracheal, and bronchial stenosis.

  • Airway stenosis represents the most common airway complication following lung transplantation, affecting between 7% and 18% of patients.
  • Idiopathic subglottic stenosis is a rare condition, mostly affecting women, with an estimated incidence of 1 in 400,000 people.
  • There are ~100,000 tracheo-bronchial stenting and dilation procedures performed annually within the United States.

Sinus

Chronic Rhinosinusitis (CRS)

Long-term inflammation of the nasal and paranasal sinus mucosa

  • CRS is one of the most common chronic medical conditions in the world.
  • 39+ million estimated people in the U.S. suffer from CRS.
  • For half of CRS sufferers, medication alone is not enough. Many choose to undergo surgery.
  • 10-30% of patients who have surgery for CRS undergo at least one more surgery later due to continued symptoms.

Leadership Team

Lixiao Wang

Founder, Chief Executive Officer & Chief Technology Officer

Prior experience includes: Lutonix, Urotronic, Boston Scientific, Bard and GIE Medical

Paul Vajgrt

Chief Operating Officer

Prior experience includes: Entellus Medical, Amphora Medical, Velocimed and Zurex Pharma

James Ness

Chief Financial Officer

Prior experience includes: BHI, Rotation Medical and Tendyne

Yan Li

Vice President, Clinical Affairs

Prior experience includes: Boston Scientific, Lutonix, Bard and Philips

Mitch Erickson

Director, R&D

Prior experience includes: Covidien, Spectranetics and Philips

Robyn Schacherer

Director, Clinical Operations

Prior experience includes: Entellus Medical and Tactile Medical

Chad Mellingen

Director, Quality

Prior experience includes: ACIST Medical Systems, Beckman Coulter and Philips

Amy Wolbeck

Consultant, Regulatory Affairs

Prior experience includes: Intersect ENT, Medtronic and Parexel

Contact us

For any inquiries or questions, please fill out the following form.

© 2025 Airiver Medical